Back to search
Secondary Hyperparathyroidism Due to Renal Causes
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Secondary Hyperparathyroidism Due to Renal Causes trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Secondary Hyperparathyroidism Due to Renal Causes trials you may qualify forSafety, Efficacy, PK and PD of CTAP101 (calcifediol) ER Capsules for SHPT in HD Patients VDI
The purpose of this study is to characterize changes in quality of life in patients who had undergone parathyroidectomy for secondary hyperparathyroidism due to…
1. Study content: This is a multicentre, double-blind, randomised controlled study to determine the optimal dose and duration of treatment for the correction of…
An Open-Label, Repeated-Dose Safety, Efficacy, Pharmacokinetic and Pharmacodynamic Study of Oral CTAP101 Capsules, Immediate- Release (IR) Calcifediol, High-Dos…
In this study, investigators measure patient's voice frequency, swallowing function, and O2 desaturation of the 6 mins walking test before surgery and 4 months…
To demonstrate the superiority of paricalcitol treatment at early renal post-transplantation (M6) in the control of iPTH (Intact parathyroid hormone) compared t…